The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Abiomed Future Growth

How is Abiomed forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

Future Growth Score

1/6

Future Growth Score 1/6

-2.5%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

NasdaqGS:ABMD - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
3/31/2025	1,488	262	N/A	446	2
3/31/2024	1,265	226	N/A	360	3
3/31/2023	1,144	269	N/A	299	3
9/30/2022	1,074	267	217	251	N/A
6/30/2022	1,056	218	263	298	N/A
3/31/2022	1,032	137	250	285	N/A
12/31/2021	1,003	133	246	293	N/A
9/30/2021	974	149	233	282	N/A
6/30/2021	935	154	248	298	N/A
3/31/2021	848	226	221	275	N/A
12/31/2020	813	200	237	275	N/A
9/30/2020	803	208	246	285	N/A
6/30/2020	798	159	240	282	N/A
3/31/2020	841	203	271	315	N/A
12/31/2019	841	245	257	299	N/A
9/30/2019	820	221	243	284	N/A
6/30/2019	797	258	229	270	N/A
3/31/2019	769	259	208	252	N/A
12/31/2018	737	222	191	238	N/A
9/30/2018	690	190	155	220	N/A
6/30/2018	641	165	142	203	N/A
3/31/2018	594	112	137	193	N/A
12/31/2017	544	90	103	173	N/A
9/30/2017	505	92	93	151	N/A
6/30/2017	475	77	70	125	N/A
3/31/2017	445	52	65	115	N/A
12/31/2016	415	48	69	100	N/A
9/30/2016	386	43	69	92	N/A
6/30/2016	359	42	N/A	92	N/A
3/31/2016	330	38	N/A	77	N/A
12/31/2015	303	126	N/A	73	N/A

Earnings vs Savings Rate: ABMD's earnings are forecast to decline over the next 3 years (-2.5% per year).

Earnings vs Market: ABMD's earnings are forecast to decline over the next 3 years (-2.5% per year).

High Growth Earnings: ABMD's earnings are forecast to decline over the next 3 years.

Revenue vs Market: ABMD's revenue (13.1% per year) is forecast to grow faster than the US market (6.9% per year).

High Growth Revenue: ABMD's revenue (13.1% per year) is forecast to grow slower than 20% per year.

Future ROE: ABMD's Return on Equity is forecast to be low in 3 years time (15.1%).